secwatch / observer
8-K filed February 9, 2023, 6:59 PM ET CIK 0000727207
other material confidence high sentiment negative materiality 0.85

Accelerate Diagnostics, Inc: auditor change — Accelerate Diagnostics restates 2022 quarterly reports; notes misclassification, going concern doubt

Accelerate Diagnostics, Inc

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Accelerate Diagnostics, Inc reported that prior financial statements should not be relied upon.

Action
non reliance
Auditor
Ernst & Young LLP
Exact text from the filing
hould no longer be relied upon due to the error in the balance sheet classification of the Company’s 2.50% Senior Convertible Notes due 2023 (the “Notes”) described below. In March and April 2018, the Company issued $171.5 million aggregate principal amount of Notes, which have a maturity date of March 15, 2023, unless earlier converted or repurchased. Between September 2021 and August 2022, the Company entered into certain exchange transactions pursuant to which the Company exchanged $114.9 million aggregate principal amount of Notes for one or a combination of: shares of the Company’s common stock, a secured promissory note and/or warrants to purchase the Company’s common stock. As of the date of this Current Report on Form 8-K, $56.6 million aggregate principal amount of Notes remain outstanding. The balance sheets contained in each of the 2022 Interim Financial Statements classified
View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR
accession 0001104659-23-017653
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.